In a article published in the February 2013, Harm Reduction Journal entitled, “Perceptions of cannabis as a stigmatized medicine: a qualitative descriptive study” authors Joan L Bottorff, Laura JL Bissell, Lynda G Balneaves, John L Oliffe, N Rielle Capler and Jane Buxton, state, “Experiences of stigma among those with illness and the Continue reading Cannabis as Stigmatized Medicine
Treatment of Crohn’s Disease with Cannabis: An Observational Study Timna Naftali MD1, Lihi Bar Lev BA2, Doron Yablekovitz MD1, Elisabeth Half MD1 and Fred M. Konikoff MD1 In a recent study and the first of its kind, Cannabis has Continue reading Chron’s Disease & Cannabis
In a study by Ashley C. Bradford1 and W. David Bradford2, out of the University of Georgia, it was shown that “national overall reductions in Medicare program and enrollee spending when states implemented medical marijuana laws were estimated to be $165.2 million per year Continue reading Medical Marijuana Laws Reduce Prescription Medication Use In Medicare Part D
A Pilot Study Assessing the Impact of Medical Marijuana on Executive Function Preliminary evidence from a new study led by McLean Hospital’s Staci Gruber, PhD, director of the Marijuana Investigations for Neuroscientific Discovery (MIND) program, suggests that medical marijuana Continue reading McLean Hospital Study Finds That Medical Marijuana Use May Improve Cognitive Performance
In a 2014 report of a study conducted by Marcus A. Bachhuber, MD; Brendan Saloner, PhD; Chinazo O. Cunningham, MD, MS to “determine the association between the presence of state medical cannabis laws and opioid analgesic overdose mortality,” they wrote, “increased access to medical cannabis may reduce Continue reading Medical Cannabis Laws and Opioid Analgesic Overdose Mortality in the United States, 1999-2010
In a March 18, 2016 report, the Center for Disease Control (CDC) released its guidelines on Prescribing Opioids for Chronic Pain. In this article, the CDC cautions clinicians in testing for substances “for which results would not affect patient management.” “Clinicians should Continue reading CDC Guideline for Prescribing Opioids for Chronic Pain — United States, 2016
We are pleased to present our synopsis of the changes to the Oregon Medical Marijuana Program made by House Bill 3400. We have published it on our website so that you can download it for your files. We are asking Continue reading Patients, Growers, and Caregivers. What HB 3400 means to you.
(This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.*) Abstract We present a case of a 27-year-old man with Continue reading Limited Study Shows Promise for Idiopathic Recurrent Angioedema
Reprinted without permission Free Radic Biol Med. 2014 Mar;68:260-7. doi: 10.1016/j.freeradbiomed.2013.12.026. Epub 2014 Jan 4. Cannabidiol protects liver from binge alcohol-induced steatosis by mechanisms including inhibition of oxidative stress and increase in autophagy. . Abstract Acute alcohol drinking induces steatosis, Continue reading Cannabidiol Protects Liver
Reprinted without permission David Powell, Rosalie Liccardo Pacula, Mireille Jacobson NBER Working Paper No. 21345 Issued in July 2015 NBER Program(s): HC HE Many medical marijuana patients report using marijuana to alleviate chronic pain from musculoskeletal problems and other sources. If marijuana Continue reading Do Medical Marijuana Laws Reduce Addictions and Deaths Related to Pain Killers?